Previous close | 3.1840 |
Open | 3.1420 |
Bid | 3.2450 x 0 |
Ask | 3.3950 x 0 |
Day's range | 3.1420 - 3.1420 |
52-week range | 1.7590 - 3.9030 |
Volume | |
Avg. volume | 1,287 |
Market cap | 750.187M |
Beta (5Y monthly) | 1.24 |
PE ratio (TTM) | ∞ |
EPS (TTM) | 0.0000 |
Earnings date | 09 May 2023 - 15 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that a team from WELL Health including Hamed Shahbazi, Founder and CEO, will be participating in the Laurentian Bank Securities ("LBS") Diversified Virtual Technology Conference and the Bloom Burton & Co. Healthcare Investor Conference.
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its audited consolidated financial results for the fiscal year and fourth quarter ended December 31, 2022.
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the Company will release its Fiscal Fourth Quarter and Year End 2022 financial results for the period ended December 30, 2022, on Tuesday, March 21, 2023. The Company will hold a conference call and simultaneous webcast to discus